Mice carrying the homologous human shelterin POT1-L259S mutation linked to pulmonary fibrosis show a telomerase deficiency-like phenotype with telomere shortening with increasing mouse generations
Genes & Development · 2025
DOI: 10.1101/gad.352855.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, 2025. Verfasst von Raúl Sánchez-Vázquez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Research Cancer Centre (CNIO), Madrid E-28029, Spain. Hauptthemen laut MEDLINE: Telomere-Binding Proteins, Telomerase, Telomere Shortening, Pulmonary Fibrosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Union.
Abstract (Originalsprache)
Pulmonary fibrosis is a lethal disease associated with damaging insults to the lung and with organismal aging. The presence of short and dysfunctional telomeres has been placed at the origin of this disease in a percentage of both familial and sporadic cases. Recently, a mutation in the telomere-binding protein protection of telomeres 1 in humans ( hPOT1 ), the hPOT1-L259S mutation, was found in families with idiopathic pulmonary fibrosis. Here, we generated a Pot1a L261S knock-in mouse harboring the murine homologous hPOT1-L259S mutation. We found that the homozygous Pot1a L261S mice show shorter telomeres and degenerative pathologies in the intestine, testes, and lungs at old ages, a phenotype that is aggravated with increasing mouse generations, in striking analogy to the telomerase-deficient mouse models. Furthermore, we found that the POT1a-L261S mutant protein binds more strongly to TPP1 and to telomerase and impedes telomerase-dependent telomere lengthening in vivo. We show that telomerase activity at telomeres is reduced in the presence of POT1a-L261S, which behaves as a dominant negative mutant, thus providing a potential mechanism by which Pot1a L261S knock-in mice phenocopy the short telomere phenotype of the telomerase knockout model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Research Cancer Centre (CNIO), Madrid E-28029, Spain.
- Animal Surgery and Medicine Department, Faculty of Veterinary Science, Complutense University of Madrid, Madrid E-28040, Spain.
- Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Research Cancer Centre (CNIO), Madrid E-28029, Spain; mblasco@cnio.es pmartinez@cnio.es.
Förderung
- European Union
Zitieren
APA
Sánchez-Vázquez, R., Burgaz García-Oteyza, S., Serrano, R., Flores, J. M., Martínez, P., & Blasco, M. A. (2025). Mice carrying the homologous human shelterin POT1-L259S mutation linked to pulmonary fibrosis show a telomerase deficiency-like phenotype with telomere shortening with increasing mouse generations. Genes & Development. https://doi.org/10.1101/gad.352855.125
Vancouver
Sánchez-Vázquez R, Burgaz García-Oteyza S, Serrano R, Flores JM, Martínez P, Blasco MA. Mice carrying the homologous human shelterin POT1-L259S mutation linked to pulmonary fibrosis show a telomerase deficiency-like phenotype with telomere shortening with increasing mouse generations. Genes & Development. 2025. doi:10.1101/gad.352855.125
BibTeX
@article{SnchezVzquez2025,
author = {Sánchez-Vázquez, Raúl and Burgaz García-Oteyza, Sonia and Serrano, Rosa and Flores, Juana M and Martínez, Paula and Blasco, Maria A},
title = {Mice carrying the homologous human shelterin POT1-L259S mutation linked to pulmonary fibrosis show a telomerase deficiency-like phenotype with telomere shortening with increasing mouse generations},
journal = {Genes & Development},
year = {2025},
doi = {10.1101/gad.352855.125}
}
EUVIMED